Skip to main content
Plastic and Reconstructive Surgery Global Open logoLink to Plastic and Reconstructive Surgery Global Open
. 2026 Jun 23;14(6):e7885. doi: 10.1097/GOX.0000000000007885

Pilot Study: DermiSphere: A Novel Hydrogel with Collagen Microspheres Dermal Regeneration Template

Eric S Clayman 1,✉, Fatemeh Mirzamohammadi 1, Jenna Daddario 1, Ian L Valerio 1
PMCID: PMC13290185  PMID: 42344268

Abstract

Background:

Dermal regeneration templates (DRTs) have become an addition to the reconstructive ladder to treat various wound types. Recently, a novel hydrogel DRT (hDRT) combining a collagen-based hydrogel scaffold with embedded collagen microspheres (DermiSphere) has been introduced that permits rapid integration for early second-stage skin grafting.

Methods:

Four patients had DermiSphere hDRT applied to oncologic facial defects with plans for 2-stage reconstruction after definitive margin clearance. These defects consisted of 2 nasal, 1 forehead/glabellar, and 1 cheek. Applications involved single-layer versus 2-layer techniques followed by second-stage skin grafting.

Results:

This early pilot series indicated that DermiSphere hDRT provided for rapid vascularization to support early second-stage skin grafting. The primary defect sizes at time of hDRT application ranged from 2.1 × 2.2 cm (4.6 cm2) to 6 × 6 cm (36 cm2). Time to second-stage skin grafting ranged 7–18 days (average 11.5 d). In all applications of hDRT, the size and depth of the soft tissue defects were observed to have favorable wound contraction with a vascularized tissue bed prepared by application of the hDRT.

Conclusions:

This pilot study showed rapid hDRT vascularization permitting successful skin grafting in a relatively condensed timeframe. Additionally, layering of the hDRT was possible without significant delay to definitive skin grafting. In 1 case, immediate skin grafting at the time of hDRT placement was able to be achieved. Although some degree of wound contraction occurred in all cases, this contraction resulted in limited distortion of the adjacent tissues with acceptable functional and aesthetic results that continued to improve over time.


Takeaways

Question: Is there a dermal regenerative template capable of rapid vascularization to expedite the time to definitive reconstruction?

Findings: The 4 patients who underwent DermiSphere hydrogel dermal regeneration template (hDRT) placement all experienced vascularization of the DRT that supported second-stage skin grafting ranging from 7 to 18 days following DRT placement. One patient had immediate skin graft placement at the time of placement of an additional layer of hDRT.

Meaning: Our findings support the utility of DermiSphere hDRT in 1-stage reconstruction with overlying split-thickness skin grafting, early layering at 7 days, and expedited time to definitive reconstruction.

INTRODUCTION

Acellular dermal matrices and dermal regeneration templates (DRTs) have become a relatively recent addition to the reconstructive ladder and have been utilized throughout wound and reconstructive care.1 Typically, these biomaterials are employed in a staged manner for wound management with subsequent definitive split-thickness skin grafting (STSG) at a second-stage and delayed timeframe given the intrinsic need for vascularization to support successful skin graft take. DRTs have been utilized to treat partial and full-thickness soft tissue wounds arising from burn, trauma, oncologic, and other soft-tissue injury causes. These biomaterials have been shown to increase soft tissue bulk, can support viable soft-tissue engraftment over certain exposed vital structures, and have been proposed to reduce wound/scar contraction in certain applications. Furthermore, in cosmetically sensitive areas such as the head and neck, face, and hands/extremities, unfavorable scar contraction can cause significant functional and aesthetic deformity.

The first DRT approved by the Food and Drug Administration was the Integra bilayer DRT, which was approved in 1996 for the treatment of patients experiencing extensive burn injuries.1,2 This DRT was a xenograft-based biomaterial composed of bovine collagen and shark glycosaminoglycans.1,2 Since its introduction, the clinical scope of this product has broadened substantially to include uses well beyond burn-related reconstruction. A variety of dermal matrices and templates are now available, including xenografts, human/cadaveric-derived allografts, synthetic materials, and combination biomaterials that are included in the broader classification of DRTs.1–12

A significant disadvantage of the early market DRTs is that a delay in second-stage skin grafting for upwards of 14–28 days is often required for adequate neovascularization to take place before STSG placement. This delay in time to definitive second-stage skin grafting can increase the risk of infection, scar development, and wound contraction. It may also result in decreased mobility if used around joint or mobile soft tissue surfaces, especially if these areas are immobilized for prolonged periods. There have been various other dermal matrices and skin substitutes introduced over time and a few examples include: human-derived (Alloderm), bovine-derived (Primatrix, Matriderm), fish-based (Kerecis), and synthetics (Restrata, Novosorb). Each of these dermal matrices are biomaterials that provide a scaffold for neodermal or granulation tissue formation supporting neovascularization in support of second-stage skin grafting and/or secondary re-epithelialization.3,4 Recently, a novel DRT composed of a hydrogel-based scaffold containing embedded collagen microspheres (DermiSphere) has been introduced and proposed to possess more rapid integration and vascularization as compared to certain other available DRTs. We present the first pilot clinical case series employing the hDRT for staged reconstruction of facial oncologic defects while awaiting definitive oncologic clearance. In these cases, the patients elected for second-stage skin grafting after placement of this hDRT.

METHODS

Four patients had the DermiSphere hDRT applied to facial defects following melanoma resections. The hDRT was placed during the index resection procedure as the surgical oncology team awaited confirmation of margin status. Patient 1 was an 85-year-old woman with a 6 × 6 cm defect of the forehead, glabella, bilateral medial upper eyelids, and nasal dorsum. Patient 2 was a 90-year-old man, and patient 3 was a 65-year-old woman with defects of the nasal ala and sidewall, measuring 2.5 × 2.5 cm and 2.1 × 2.2 cm, respectively. Patient 4 was a 66-year-old man with a 3.5 × 3.5 cm right cheek defect. A traditional tie-over bolster dressing was placed over the hDRTs.

RESULTS

The primary facial oncologic defect sizes at time of hDRT application ranged from 2.1 × 2.2 cm (4.6 cm2) to 6 × 6 cm (36 cm2). Time to second-stage skin grafting ranged 7–18 days (average 11.5 d). This pilot case series indicated vascularization of the hDRT as early as 6 days after the removal of the initial bolster dressing. In all 4 cases, the treated facial oncologic defects were observed to show acceptable contour and appearance without significant adjacent tissue distortion despite upwards of 30%–40% wound contraction. Figure 1 shows the first ever DermiSphere patient case with the significant forehead defect encountered after melanoma resection. Figure 1B shows the neovascularization and tissue that has formed via support of the hDRT, and Figure 1C shows the neodermal component following gentle debridement of the overlying granulation tissue. The overall wound size contracted by approximately 40% from the time the hDRT was placed until the STSG was fully healed. This caused scarring around the periphery of the wound that was ultimately approximately 40% of the initial defect. Patient 2 had vascularization of the hDRT at 12 days that would have likely supported an STSG; however, due to the depth of the defect and in an effort to better recreate the nasal ala, an additional application of the hDRT was performed. The layered hDRT showed vascularization 6 days following the second hDRT application, and the patient underwent STSG placement at that time. There was a notable decrease in defect size and depth, and the patient did experience mild contraction and notching of the nasal ala; however, this had no negative functional impact on his nasal airflow and/or nasal ala collapse on clinical examination (Fig. 2). The overall wound size contracted by approximately 40% from the time the hDRT was placed until the STSG was fully healed. Patient 3 had vascularization of the hDRT at 7 days. Due to the depth of the defect, an additional layer of hDRT was placed along with an immediate overlying 0.010-inch thickness STSG. Her skin graft was noted to be healing well when the bolster was removed at 7 days, and she had no alar retraction or functional nasal deformity noted on clinical follow-ups (Fig. 3). The overall wound size contracted by approximately 30% from the time the hDRT was placed until the STSG was fully healed. Patient 4 had vascularization of the hDRT at 11 days with filling of the soft tissue defect. He initially had a notable contour deformity at 25 days following skin grafting; however, his 4 month follow-up results show an acceptable contour with the adjacent tissues (Fig. 4). The overall wound size showed significant contraction from the time the hDRT was placed until the STSG was fully healed. This caused scarring around the periphery of the wound that was ultimately approximately one third of the initial defect. Autologous skin grafting consisted of traditional STSGs and/or spray-skin based autologous skin cells for their definitive reconstruction.

Fig. 1.

Fig. 1.

Patient 1, with defect of the forehead, glabella, bilateral medial upper eyelids, and nasal dorsum, shown (A) before hDRT placement; (B) 10 days following hDRT placement; (C) 14 days following hDRT placement; (D) 5 weeks following STSG and ReCell placement; and (E) 4 months following STSG and ReCell placement.

Fig. 2.

Fig. 2.

Patient 2, with defect of the left nasal sidewall and ala, shown (A) before hDRT placement; (B) 18 days after first hDRT placement, 6 days after second hDRT placement; (C) Following STSG placement; (D) 25 days after STSG placement; and (E) 5 months following STSG placement.

Fig. 3.

Fig. 3.

Patient 3, with defect of the right nasal sidewall and ala, shown (A) 7 days after first Hdrt placement, following second hDRT placement; (B) Following immediate STSG over second hDRT placement; (C) 18 days after STSG placement; and (D) 5 months after STSG placement.

Fig. 4.

Fig. 4.

Patient 4, with defect of the right cheek, shown (A) before hDRT placement; (B) Following hDRT placement; (C) 11 days after hDRT placement; (D) 25 days after STSG and ReCell placement; and (E) 4 months following STSG and ReCell placement.

DISCUSSION

Since the introduction of the first commercially available DRT, these biomaterials have become an accepted addition to the reconstructive ladder. The first available DRT consisted of a macroporous scaffold of bovine type 1 collagen cross-linked with chondroitin-6-sulfate and an overlying silicone sheet. Since its introduction to the reconstructive surgery field, a wide variety of other dermal matrices and templates have become commercially available. These DRTs are bioengineered scaffolds that support cellular migration, adhesion, and ingrowth to provide for sufficient revascularization in support of second-stage skin grafting.1,2 Although these DRTs are sourced from a broad range of xenografts, human-derived cadaver allografts, and synthetic biomaterials, each DRT has been proposed to support neodermal vascularized tissue generation and/or support many different wound care applications.1–12

Neovascularization of most commercially available DRTs characteristically begins by the end of the second week, and an STSG may be placed at around 14–28 days after initial application.5,6 The time required for neovascularization of certain DRTs has various disadvantages, including delay in definitive skin graft placement; potential for infection and loss of an expensive biomaterial; and concern for distortion in certain aesthetic areas, such as the facial area, where wound contraction can cause significant functional and aesthetic deformity. Additionally, long-term clinical studies comparing the rates of contracture and skin texture among the different DRTs are lacking and somewhat complicated by their different compositions and/or properties. For example, a study by Truong et al showed that Alloderm produced less contraction and the thickest new “dermis” compared to Integra DRT.8 In a recent prospective randomized trial of patients with burn contractures, application of Matriderm was compared to application of Integra, and it was shown that patients treated with Integra had “better improvements” in mobility and skin quality at 1-year posttreatment but lacked longer term follow-up. Other studies have shown that 1-stage Matriderm and STSG produces skin grafts similar to normal skin in terms of vascularity, elasticity, pliability, texture, and color.10

Naturally polymerized hydrogels can incorporate biocompatible materials, such as collagen, in an environment similar to the extracellular matrix.11 Their low diffusion coefficients enhance oxygen permeability and have a pro-angiogenic and minimally immunogenic environment optimal for tissue regeneration.12 DermiSphere hDRT was developed based upon the observation that cells tend to rapidly invade and integrate into hydrogels due to interfaces of differential density. This differential density can be enhanced via embedding collagen microspheres within the hydrogel, enhancing cellular adhesion, infiltration, and proliferation.11 This rapid and robust cell invasion is rather quickly followed by neovascularization of the hydrogel throughout its ~1.2 mm thickness.

In our series, this hydrogel-based DRT containing collagen microspheres supported early second-stage skin grafting without compromise in skin graft take and with acceptable functional and aesthetic results. These facial defects were significant in depth, and the advantage of the hDRT was that it provided a scaffold for rapid cellular ingrowth to expeditiously decrease the depth of these soft-tissue defects when placed at the time of the index skin cancer extirpation surgery. As illustrated in the case of patient 1, a sizeable defect involving multiple facial subunits was encountered. Due to the size, depth, and multi-subunit nature this defect, options discussed with the patient included local flap-based reconstruction options and primary full-thickness skin grafting, as well as 2-stage options, including DRT placement followed by second-stage skin grafting once final margin clearance was achieved. However, after observing the favorable contraction coupled with vascularized neodermal tissue to support autologous skin grafting after the hDRT placement, the patient opted for second-stage skin grafting, as she desired to avoid additional scars from the various local flap options proposed. Under these considerations, this dermal matrix provided her with acceptable contour without significant adjacent tissue distortion and minimal skin graft scar burden, which were expressed goals of interest to her. In this case, a limitation of this product and reconstructive approach is that she did still experience wound contraction, and her older age and associated increased adjacent tissue laxity likely contributed to the ability of the tissues to tolerate this wound contraction more so than in a younger patient with less tissue laxity.

Patients 2 and 3 both had multisubunit defects of considerable size and depth of the nasal area. Local flaps such as a bilobed flap, nasolabial flap or forehead flap were discussed to reconstruct these defects after margin clearance, as was full thickness skin grafting as an alternative. However, both patients expressed their wishes to avoid the additional incisions and scars that would have been required for these local flaps and FTSG, and they elected for placement of the hDRT at the index skin cancer extirpation surgery followed by second-stage skin grafting. These cases had hDRTs placed in a 2-layer fashion to provide additional contour in these nasal cases. Given the more rapid vascularization potential of this hDRT, which would correspond with the typical timing for pathology margin clearance at our institution, the proposed 2-stage procedure and timing seemed to meet the patients’ goals while also aiding in decreasing the depth of the defect, provide acceptable contour with the adjacent tissues, and expedite the time to definitive skin grafting. In these cases, a limitation of this product and reconstructive approach is that these patients did still experience some wound contraction. Similar to patient 1, patient 2’s older age and associated increased adjacent tissue laxity likely contributed to the ability of the tissues to tolerate this wound contraction more so than in a younger patient with less tissue laxity. Patient 2 did experience alar notching, and this was likely also due to an additional hDRT application, which prolonged the time to STSG placement and further increased his overall wound contraction. However, the layered hDRT in this case ultimately contributed to an improved contour of the reconstructed rim. In contrast to patient 2, patient 3 had an additional hDRT application with immediate overlying STSG placement, which minimized her time to definitive reconstruction. Although she still experienced wound contraction, this immediate overlying STSG application at the time of her second hDRT application likely minimized the severity of her wound contraction and minimized the development of alar notching.

Patient 4 had a defect that could have been reconstructed with a cervicofacial flap or other local flap options. However, as evident in Figure 4A, there was a large incision along his right mandible angle and border that had been made by the surgical oncology team to obtain sentinel lymph node biopsies. Therefore, we felt that the rapid vascularization potential of the hDRT while awaiting margin clearance would provide an acceptable reconstructive option for this patient. In this case, the depth of the defect was noted to be decreased; adjacent tissue distortion was minimal; and the time to definitive skin grafting after hDRT vascularization, which coincided with margin clearance, met the expressed desires and expectations of this patient. A limitation of this product and reconstructive approach is that this patient did still experience wound contraction; however, we feel that the patient overall had an acceptable final result without significant adjacent tissue distortion.

Future studies of the hDRT with comparison of 1-stage versus 2-stage skin grafting with this particular biomaterial would be of interest for a variety of soft tissue defects seen within clinical practices. Additionally, future studies comparing the hDRT to other DRTs should be performed to more objectively compare not only the outcomes across various DRTs but also the cellular and biologic responses elicited by these biomaterials within the host. These results would include early comparisons in time to vascularization, more exact timeframes to support skin grafting and/or definitive re-epithelialization, skin graft viability, rates of infection, and cost burden, as well as more long-term results including degree of scar contracture and skin graft quality.

The limitations of this study include that this is a small pilot case series with 4 patients with a relatively short follow-up of 6–7 months. Future studies will be performed with larger case series along with longer follow-up and histological evaluation of revascularization. The earliest staged skin grafting was performed 6 days following final hDRT placement with the latest at 14 days following final hDRT placement. The STSG could have potentially been performed earlier in many of these cases; however, logistical reasons and scheduling conflict considerations affected the second-stage timing of STSG placement. The hDRT allowed immediate overlying STSG placement and additional hDRT applications (ie, layering of the product for contour considerations) at 7–12 days to decrease wound depth and optimize overall contour with the adjacent tissue. These scenarios demonstrate the versatility of the DermiSphere hDRT in 1-stage reconstruction with overlying STSG and early layering within 7 days or 2-stage reconstruction with overlying STSG at 6 days following final hDRT placement. These skin grafts were harvested with a dermatome from the postauricular skin, and as a result, these donor sites were well hidden in the postauricular skin. Additionally, the donor sites healed rapidly due to the thin nature of the skin grafts that were required for placement over the DRT. All patients had significantly decreased wound size without significant adjacent tissue distortion. The rapid integration of the DermiSphere hDRT minimized the detrimental aspects of secondary intention healing by expediting the time to definitive reconstruction of complex multiple subunit facial defects. This work is the first to report the early clinical findings of this novel hDRT, which may possess inherent benefits as compared to other commercially available biomaterials.

DISCLOSURES

Dr. Valerio is a consultant for Axogen, Inc., Integra Lifesciences Corporation, and Checkpoint Surgical, Inc. The other authors have no financial interest to declare in relation to the content of this article.

PATIENT CONSENT

Patients provided written consent for the use of their images.

Footnotes

Published online 23 June 2026.

Limitations regarding long-term follow-up inherently exist in this article type.

Disclosure statements are at the end of this article, following the correspondence information.

REFERENCES

  • 1.Janis JE, Kwon RK, Attinger CE. The new reconstructive ladder: modifications to the traditional model. Plast Reconstr Surg. 2011;127:205S–212S. [DOI] [PubMed] [Google Scholar]
  • 2.Taupin P, Gandhi A, Saini S. Integra® dermal regeneration template: from design to clinical use. Cureus. 2023;15:e38608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dickson K, Lee KC, Abdulsalam A, et al. A histological and clinical study of MatriDerm® use in burn reconstruction. J Burn Care Res. 2023;44:1100–1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shah R, Rodrigues R, Phillips V, et al. The use of artificial dermal substitutes for repair of the donor site following harvesting of a radial forearm free flap: a systematic review. J Plast Reconstr Aesthet Surg. 2024;88:501–516. [DOI] [PubMed] [Google Scholar]
  • 5.Moiemen NS, Staiano JJ, Ojeh NO, et al. Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plast Reconstr Surg. 2001;108:93–103. [DOI] [PubMed] [Google Scholar]
  • 6.Integra bilayer wound matrix treatment guidelines. Integra LifeSciences; 2017. Available at https://products.integralife.com/file/general/1510596348.pdf. Accessed October 19, 2025.
  • 7.Kemp Bohan PM, Cooper LE, Fletcher JL, et al. Impact of dermal matrix thickness on split-thickness skin graft survival and wound contraction in a single-stage procedure. Int Wound J. 2022;19:370–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mason SA, Pham TN. Use of dermal regenerative templates for burns. J Burn Care Res. 2023;44:S19–S25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Truong AT, Kowal-Vern A, Latenser BA, et al. Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds. 2005;4:e4. [PMC free article] [PubMed] [Google Scholar]
  • 10.Demircan M, Cicek T, Yetis MI. Preliminary results in single-step wound closure procedure of full-thickness facial burns in children by using the collagen-elastin matrix and review of pediatric facial burns. Burns. 2015;41:1268–1274. [DOI] [PubMed] [Google Scholar]
  • 11.Weisel A, Cohen R, Spector JA, et al. Accelerated vascularization of a novel collagen hydrogel dermal template. J Tissue Eng Regen Med. 2022;16:1173–1183. [DOI] [PubMed] [Google Scholar]
  • 12.Gupta B, Agarwal R, Alam MS. Hydrogels for wound healing applications. In: Rimmer S, ed. Biomedical Hydrogels: Biochemistry, Manufacture and Medical Applications. Woodhead Publishing; 2011:184–227. [Google Scholar]

Articles from Plastic and Reconstructive Surgery Global Open are provided here courtesy of Wolters Kluwer Health

RESOURCES